Aboshanab, Khaled

aboshanab2012@pharma.asu.edu.eg
Interests: Molecular biology, Microbiology, Biotechnology, Immunology and genetics,
Internal ID: rp05544
  • 904 Scopus Citations
  • 318 PubMed Citations
Network Lab View Statistics Email Alert RSS Feed

Profile

Loading... 2 0 20 0 false
 
Full Name
Aboshanab, Khaled
 
Email
aboshanab2012@pharma.asu.edu.eg
 
Other emails
 
ORCID
 
Scopus Author ID
 
Biography
Biography name: Khaled Mohamed Anwar Aboshanab Address: Department of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Postal code 11566, Abbassia, Cairo, Egypt. Email: aboshanab2012@pharma.asu.edu.eg ORCID : 0000-0001-8286-4352 Google scholar profile: https://scholar.google.com/citations?user=zXFaTBQAAAAJ&hl=en Faculty Website: http://pharma.asu.edu.eg/article.php?action=show&id=8396#.W1hLutUza70

Publications

Results 141-160 of 165 (Search time: 0.0 seconds).

Issue DateTitleAuthor(s)
141Dec-2024Nanosponge hydrogel of octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl) propanoate of Alcaligenes faecalisEl-Sayed, Sayed E; Abdelaziz, Neveen A; El-Housseiny, Ghadir S; Aboshanab, Khaled 
22Dec-2024Colistin, doxycycline and Labetalol-meropenem combination are the most active against XDR-Carbapenem-resistant Acinetobacter baumannii: Role of a novel transferrable plasmid conferring carbapenem resistanceSelim, Heba Mohammed Refat M; Gomaa, Fatma Alzahraa M; Alshahrani, Mohammad Y; Aboshanab, Khaled ; Elsayed, Khaled M; Kamel, Noha A
23Dec-2024Biologically active metabolites of Alcaligenes faecalis: diversity, statistical optimization, and future perspectivesEl-Sayed, Sayed E; Abdelaziz, Neveen A; Alshahrani, Mohammad Y; El-Housseiny, Ghadir S; Aboshanab, Khaled 
2420-Dec-2024Whole genome sequence and LC-Mass for identifying antimicrobial metabolites of Bacillus licheniformis endophyteSoliman, Nourhan K; Abbas, Ahmad M; Alshahrani, Mohammad Y; Aboshanab, Khaled ; El-Tayeb, Wafaa N
2531-Dec-2024Hematological, inflammatory and serological responses among COVID-19 patients admitted to intensive care unitMorgan, Mirette A; Saleh, Sarra E; Salamoni, Azza H; Alshahrani, Mohammad Y; Aboshanab, Khaled 
263-Jan-2025Response Surface D-Optimal Design for Optimizing Fortimicins Production by Micromonospora olivasterospora and New Synergistic Fortimicin-A-Antibiotic CombinationsSelim, Heba Mohammed Refat M; Gomaa, Fatma Alzahraa M; Alshahrani, Mohammad Y; Aboshanab K. 
2713-Jan-2025Deciphering the nature and statistical optimization of antimicrobial metabolites of two endophytic bacilliIsleem, Raghda S; Eid, Ahmed M; Hassan, Saad El-Din; Aboshanab, Khaled ; El-Housseiny, Ghadir S
28Mar-2025Phage therapeutic delivery methods and clinical trials for combating clinically relevant pathogensSelim, Heba Mohammed Refat M; Gomaa, Fatma Alzahraa M; Alshahrani, Mohammad Y; Morgan, Radwa N; Aboshanab, Khaled 
2912-Mar-2025Recent insights on phage therapy against multidrug-resistant Acinetobacter baumanniiElshamy, Ann A; Kamal, Sandra K; Mahmoud, Mariam T; Elhasany, Aya M; Shady, Aya A; Mohamed, Sherok A; Abd-Elmaaboud, Hasna A; El-Awady, Nour E; Mohamed, Rana A; El-Mirghany, Sara A; El-Hady, Sarraa W; Abd-ElRahman, Mohamed M; Aboshanab, Khaled 
301-Apr-2025In vitro and preclinical evaluation of the antifungal activity of 6-methoxy-1 H-indole-2-carboxylic acid produced by Bacillus toyonensis strain OQ071612 formulated as nanosponge hydrogelEl-Sayed, Sayed E; Abdelaziz, Neveen A; El-Housseiny, Ghadir S; Aboshanab, Khaled 
311-Apr-2025Role of CRISPR-Cas system as a new approach in fighting the antimicrobial resistance of bacterial and viral pathogensSelim, Heba Mohammed Refat M.; Gomaa, Fatma Alzahraa M.; Alshahrani, Mohammad Y.; Aboshanab K.M.A 
3226-Apr-2025A novel thermostable lytic phage vB_EF_Enf3_CCASU-2024-3 against clinical Enterococcus faecium and Enterococcus faecalisAmr, Rana M; Bishr, Amr S; Saad, Bishoy T; Alshahrani, Mohammad Y; Aboshanab, Khaled ; Hassouna, Nadia A
3328-Apr-2025Deciphering hygromycin B biosynthetic pathway and D-optimal design for production optimizationSuliman, Muath; Bishr, Amr S; Aboshanab, Khaled 
3417-May-2025In vitro, genomic characterization and pre-clinical evaluation of a new thermostable lytic Obolenskvirus phage formulated as a hydrogel against carbapenem-resistant Acinetobacter baumanniiSherif, Mahmoud M; Abdelaziz, Neveen A; Alshahrani, Mohammad Y; Saleh, Sarra E; Aboshanab, Khaled 
3520-May-2025D-optimal design model and biosynthetic pathway for gentamicin production by Micromonospora purpureochromogenes NRRL B-16094Suliman, Muath; Bishr, Amr S; Tohamy, Sally T K; Alshahrani, Mohammad Y; Aboshanab, Khaled 
3618-Jun-2025Anticancer, antimicrobial and molecular docking analysis of newly synthesized iodoquinazoline derivativesAboshanab K. M. ; Bishr, Amr S; Jusoh, Siti Azma; Alshahrani, Mohammad Y; Rahman, Khondaker Miraz; Alafeefy, Ahmed M
372-Aug-2025Genomic characterization and pre-clinical evaluation of a new polyvalent lytic Loughborough phageSherif, Mahmoud M; Abdelaziz, Neveen A; Saleh, Sarra E; Aboshanab, Khaled 
3811-Aug-2025Recent insights on challenges encountered with phage therapy against gastrointestinal-associated infectionsYoussef, Reem A; Shebl, Rania I; Aboshanab, Khaled ; Sakr, Masarra M
39Sep-2025Evaluation of the taxonomic classification tools and visualizers for metagenomic analysis using the Oxford nanopore sequence databaseBebawy, Abraam S; Saad, Bishoy T; Saad, Mina T; Mosaad, Gamal S; Gomaa, Fatma Alzahraa M; Alshahrani, Mohammad Y; Aboshanab, Khaled 
40Sep-2025Solid-state fermentation of pristinamycin by Streptomyces pristinaespiralis NRRL ISP-5338 using D-optimal designSuliman, Muath; Bishr, Amr S; Tohamy, Sally T K; Alshahrani, Mohammad Y; Aboshanab, Khaled